Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Claudin 18.2”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Early research (Phase 1)Looking for participantsNCT05857332
What this trial is testing

SG1906 for CLDN18.2-Positive Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors
Hangzhou Sumgen Biotech Co., Ltd. 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03816163
What this trial is testing

Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer

Who this might be right for
Pancreatic CancerMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 393
Early research (Phase 1)Ended earlyNCT04735796
What this trial is testing

Study of LM-102 in Subjects in Advanced Tumors

Who this might be right for
Advanced Solid Tumors
LaNova Medicines Limited 9
Testing effectiveness (Phase 2)Looking for participantsNCT06962137
What this trial is testing

Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer

Who this might be right for
Gastric Cancer Adenocarcinoma MetastaticGastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
Universitaire Ziekenhuizen KU Leuven 100
Testing effectiveness (Phase 2)Looking for participantsNCT05994001
What this trial is testing

Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody

Who this might be right for
Biliary Tract CancerCandonilimabClaudin 18.2
Shanghai Zhongshan Hospital 96
Very early researchNot Yet RecruitingNCT07394205
What this trial is testing

Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer

Who this might be right for
Advanced Gastric and Pancreatic Cancer
First Affiliated Hospital of Wenzhou Medical University 18
Not applicableUnknownNCT05952375
What this trial is testing

Exploratory Clinical Trial on the Safety, Efficacy, and Pharmacokinetics of XKDCT086 (iPD-1-Claudin18.2-CAR-T) in Claudin 18.2 Positive Advanced Solid Malignant Tumors: a Single Center, Single Arm, Dose-increasing Trial

Who this might be right for
Gastric Cancer
The Affiliated Hospital of Qingdao University 9
Not applicableLooking for participantsNCT07301814
What this trial is testing

Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors

Who this might be right for
Gastric CancerPancreatic CancerCholangiocarcinoma Cancer+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 56
Early research (Phase 1)Looking for participantsNCT05365581
What this trial is testing

ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 398
Not applicableAvailableNCT06048081
What this trial is testing

Early Access Program for Zolbetuximab

Who this might be right for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma CancerLocally Advanced Unresectable Gastric Adenocarcinoma CancerMetastatic Gastric Adenocarcinoma Cancer+1 more
Astellas Pharma Global Development, Inc.
Large-scale testing (Phase 3)Active Not RecruitingNCT06351020
What this trial is testing

LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.

Who this might be right for
Locally Advanced or Metastatic GC and GCJ Adenocarcinoma
LaNova Medicines Zhejiang Co., Ltd. 387
Early research (Phase 1)Looking for participantsNCT07024615
What this trial is testing

ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Astellas Pharma Global Development, Inc. 25
Not applicableLooking for participantsNCT06902545
What this trial is testing

Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

Who this might be right for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more
Astellas Pharma Korea, Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07151872
What this trial is testing

Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer

Who this might be right for
CLDN18.2-positive Advanced Biliary Tract Cancer
Qilu Pharmaceutical Co., Ltd. 120
Early research (Phase 1)Looking for participantsNCT05837299
What this trial is testing

IMC008 for Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Changhai Hospital 18
Early research (Phase 1)Not Yet RecruitingNCT06166472
What this trial is testing

Evaluate the Safety, Tolerance, Pharmacokinetics, and Preliminary Antineoplastic Activity of AK132 in Advanced Malignant Solid Tumor

Who this might be right for
Advanced Malignant Solid Tumor
Akeso 72
Early research (Phase 1)Not Yet RecruitingNCT06134960
What this trial is testing

NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor

Who this might be right for
Gastric CancerPancreatic CancerSolid Tumor
Peking University 12
Very early researchUnknownNCT05937919
What this trial is testing

68Ga-PMD22 PET/CT Examination Targeting CLDN18.2

Who this might be right for
Gastrointestinal Cancer
Peking Union Medical College Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT05934331
What this trial is testing

A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study

Who this might be right for
Malignant Neoplasms of Digestive Organs
LaNova Medicines Zhejiang Co., Ltd. 276
Early research (Phase 1)Looking for participantsNCT06084286
What this trial is testing

Dual-targeting CLDN18.2 and PD-L1 CAR-T for Patients with CLDN18.2-positive Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Sichuan University 29
Load More Results
377